| |||
| задержка <тромба> в нижней полой вене (The long-term caval patency rate was 97.6%, and there was protection against recurrent embolism in 97% of patients with only. Pustelga) | |||
| |||
| задержка <тромба> в нижней полой вене (The long-term caval patency rate was 97.6%, and there was protection against recurrent embolism in 97% of patients with only. Pustelga) | |||
